热门资讯> 正文
对齐医疗集团提出驳回举报人诉讼的动议
2026-08-19 01:19
- Alignment Healthcare (ALHC) has filed a motion to dismiss a whistleblower lawsuit in which a former company executive accused the Medicare-driven health insurer of manipulating its finances to boost its stock price.
- Shares of the Orange, California-based firm plunged in early July after media reports indicated that ex-employee Hakan Kardes filed the case in a federal court in Santa Ana. Citing a court filing, Bloomberg reported that the company has dismissed the allegations as a “case of sour grapes.”
- “A third-party investigation found that Hakan Kardes’ Sarbanes-Oxley (SOX) whistleblower claims are false; there is no basis for his allegations," Alignment (ALHC) said in a statement.
- The company cited multiple reasons for the dismissal, including that the plaintiff filed whistleblower claims too late, and added that Kardes sued only after realizing that an in-house restructuring initiative didn’t roll out as he expected.
More on Alignment Healthcare
- Alignment Healthcare: The Drawdown I Told You To Wait For Has Arrived (Rating Upgrade)
- Alignment Healthcare, Inc. (ALHC) Q2 2026 Earnings Call Transcript
- Alignment Healthcare: A 33% Grower Worth Owning At 48x Forward Earnings, Just Not Yet
- Alignment Healthcare forecasts $5.20B-$5.23B 2026 revenue while raising membership outlook to 298k-301k
- Alignment Healthcare GAAP EPS of $0.17 beats by $0.04, revenue of $1.3B misses by $10M
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。